NEGXF Stock: NexgenRx Inc. Stock Price, Analysis & Insights
Get live NEGXF stock price $0.33, comprehensive NexgenRx Inc. stock analysis, charts, news, and expert forecast. Real-time NEGXF stock data and investment insights.
Loading chart data...
NexgenRx Inc. (NEGXF) Overview
NexgenRx Inc. (NEGXF) is a publicly traded company in the Healthcare sector , specifically within the Medical - Healthcare Plans industry . As of the latest trading session, NEGXF trades at $0.33 with a market capitalization of 23.11M . Over the past 52 weeks, NEGXF has traded between $0.19 and $0.33 , with the current price positioned at approximately 100% of this range . The stock currently t...
Key Takeaways
- Operates in the Healthcare sector (Medical - Healthcare Plans)
- Market cap: 23.11M
- Current price: $0.33
- 52-week range: $0.19 - $0.33
- P/E ratio: 16.25
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
NexgenRx Inc., established in 2003 and based in Toronto, Canada, functions as a third-party administrator for health benefit plans. The company's primary role involves efficiently managing, adjudicating, and processing payments for prescription drug,...
Company Information
- CEO
- Ronald C. Loucks
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- Employees
- 20
Contact Information
- Website
- https://www.nexgenrx.com
- Address
- 185 The West Mall
- Country
- CA
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 16.3)
✓ Lower volatility stock (Beta: 0.53) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for NexgenRx Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for NexgenRx Inc.
- ⚠Investors should consider how NexgenRx Inc. fits within their overall portfolio allocation
Market Cap
23.11M
P/E Ratio (TTM)
16.25
Beta
0.53
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare NEGXF with peer companies:
- Price
- $0.16
- Market cap
- 30.32M
- Price
- $0.33
- Market cap
- 14.25M
- Price
- $0.05
- Market cap
- 14.78M
- Price
- $0.21
- Market cap
- 14.81M
- Price
- $0.26
- Market cap
- 15.88M
- Price
- $0.06
- Market cap
- 15.16M
- Price
- $0.07
- Market cap
- 8.78M
- Price
- $0.03
- Market cap
- 13.71M
- Price
- $2.11
- Market cap
- 13.49M
- Price
- $0.82
- Market cap
- 13.91M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.